Physician profile
David Liu
NPI 1043210768
$56,768.34
in general payments reported to CMS, 2019-2025
11 companies · $16K in 2025
The $16K reported for 2025 was more than what 92% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,027 · 2020: $3,732 · 2021: $1,785 · 2022: $2,585 · 2023: $5,567 · 2024: $24K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $41K · Food and Beverage: $4,858 · Education: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $40,655.00 |
| Food and Beverage | $4,858.27 |
| Education | $125.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $43,997.02 | 2019-2025 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $6,337.27 | 2021-2025 | Avalus, Penditure, Cardioblate |
| Abbott Laboratories | $2,007.54 | 2019-2025 | Mitraclip, 2nd Gen Centrimag Primary Console, Triclip |
| Medtronic Vascular, INC. | $1,845.34 | 2019-2020 | |
| Stryker Corporation | $743.33 | 2022-2024 | Gamma, T2 Alpha |
| Elutia, INC. | $660.37 | 2020-2022 | |
| Abiomed | $593.32 | 2019-2022 | |
| Atricure, INC. | $369.80 | 2019-2024 | |
| Baxter Healthcare | $160.00 | 2023 | Fluid Sys - Plasma-Lyte |
| Merck Sharp & Dohme LLC | $31.23 | 2024 | Keytruda, Welireg |
| Globus Medical, INC. | $23.12 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.